ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1046
0,00%
Bitcoin
66.973,34
-0,16%
Brent Oil
83,76
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Scilex Holding Company (SCLX)

  7. Scilex Holding Company (SCLX) Notícias

SCLX

Scilex (SCLX)

Scilex Holding Company
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SCLX
DataHoraFonteTítuloCódigoCompanhia
14/05/202410:00GlobeNewswire Inc.Scilex Holding Company Announces Final Court Approval of a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s intent to Expand the Label for its FDA-Approved Liquid Colchicine ProNASDAQ:SCLXScilex Holding Company
13/05/202410:00GlobeNewswire Inc.Scilex Holding Company Provides Information to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common StockNASDAQ:SCLXScilex Holding Company
25/04/202417:01GlobeNewswire Inc.Scilex Holding Company Announces Closing of $15 Million Registered Direct OfferingNASDAQ:SCLXScilex Holding Company
24/04/202409:00GlobeNewswire Inc.Scilex Holding Company Announces $15 Million Registered Direct OfferingNASDAQ:SCLXScilex Holding Company
16/04/202410:00GlobeNewswire Inc.Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other AdNASDAQ:SCLXScilex Holding Company
09/04/202410:00GlobeNewswire Inc.Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing PoolNASDAQ:SCLXScilex Holding Company
27/03/202410:00GlobeNewswire Inc.Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a DividendNASDAQ:SCLXScilex Holding Company
21/03/202410:30GlobeNewswire Inc.Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured PatientsNASDAQ:SCLXScilex Holding Company
20/03/202412:00GlobeNewswire Inc.Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is NeededNASDAQ:SCLXScilex Holding Company
20/03/202410:00GlobeNewswire Inc.Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid ColchicNASDAQ:SCLXScilex Holding Company
19/03/202410:00GlobeNewswire Inc.Scilex Holding Company Announces Repayment in Full of the Remaining Balance of Convertible Debentures and Early Payment of the Senior Secured Promissory Note, Paving the Way for Future Growth and InnovationNASDAQ:SCLXScilex Holding Company
18/03/202410:00GlobeNewswire Inc.Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB® for Acute Treatment of Migraine With or Without Aura inNASDAQ:SCLXScilex Holding Company
15/03/202415:45GlobeNewswire Inc.Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.NASDAQ:SCLXScilex Holding Company
15/03/202410:00GlobeNewswire Inc.Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of SNASDAQ:SCLXScilex Holding Company
11/03/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SCLXScilex Holding Company
05/03/202418:22Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SCLXScilex Holding Company
05/03/202418:20Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCLXScilex Holding Company
05/03/202418:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SCLXScilex Holding Company
05/03/202418:01GlobeNewswire Inc.Scilex Holding Company Announces Closing of $10 Million Bought Deal OfferingNASDAQ:SCLXScilex Holding Company
05/03/202411:00GlobeNewswire Inc.Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the FirNASDAQ:SCLXScilex Holding Company
04/03/202418:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SCLXScilex Holding Company
04/03/202411:00GlobeNewswire Inc.Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information UpdatesNASDAQ:SCLXScilex Holding Company
02/03/202417:25GlobeNewswire Inc.Scilex Holding Company Announces that the Official Committee of Unsecured Creditors of Sorrento Therapeutics, Inc., has Filed a Motion with the U.S. Bankruptcy Court to Extend the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento tNASDAQ:SCLXScilex Holding Company
29/02/202419:32GlobeNewswire Inc.Scilex Holding Company Announces $10 Million Bought Deal OfferingNASDAQ:SCLXScilex Holding Company
28/02/202411:00GlobeNewswire Inc.Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.NASDAQ:SCLXScilex Holding Company
27/02/202411:00GlobeNewswire Inc.Scilex Holding Company Announces Acceptance of Abstract for Poster and Oral Presentation at the Annual Meeting of the American Academy of Pain Medicine (AAPM)NASDAQ:SCLXScilex Holding Company
26/02/202418:53GlobeNewswire Inc.Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement AgreementNASDAQ:SCLXScilex Holding Company
26/02/202411:00GlobeNewswire Inc.Scilex Holding Company Announces that ZTlido® Achieves a Major Milestone - Over One Million Patients Treated Since its Launch - and Two Additional Milestones MetNASDAQ:SCLXScilex Holding Company
23/02/202418:11Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:SCLXScilex Holding Company
20/02/202411:00GlobeNewswire Inc.Scilex Holding Company Announces Publication in Anesthesiology Journal of Results from an Investigator-Initiated Research Study Using ZTlido® for the Treatment of Chronic Neck Pain¹NASDAQ:SCLXScilex Holding Company
 Apresentando as notícias mais relevantes sobre:NASDAQ:SCLX

Seu Histórico Recente

BIT
SMFT5S
Societe Generale Effekten
EU
Q666S
Q666S
NASDAQ
AAXSCXX
Morgan Stanley Bank, N.A...
UNSW3
OBIUSDT
ORBOFI
COIN
PCNTUSD
Playcent
LSE
0LYY
LSE
NL22
Citi Fun 26
LSE
CXAU
Ubsetf Ccxaa
LATK
SUNNYUSDT
Sunny Governance Token
TSX
ILLM
Illumin
USOTC
GDPEF
Resource Capital Gold (CE)
COIN
MASSGBP
MASS Net
BOV
USIMG135
USIMG135 Ex:13,22
BIT
UB8J2F
Unicredit Bank
BIT
F39161
Vontobel Financial Produ...
NYSE
PSXP
Phillips 66 Partners
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados